BNTX vs LIVN
BioNTech SE vs LivaNova — AI-powered side-by-side comparison
| Metric | BNTX | LIVN |
|---|
| AI Score |
70
|
70
|
| Price |
$91.61
|
$81.48
|
| P/E Ratio |
-11.83×
|
23.83×
|
| ROE |
-5.7%
|
-20.2%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
68.9%
|
68.2%
|
| Debt / Equity |
0.02×
|
0.27×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
55.9
|
60.6
|
| Beta |
1.278
|
0.872
|
| Expected Upside |
+6.1%
|
+0.8%
|
AI Committee View
Current Innellis committee reasoning for BNTX versus LIVN.
The committee scores are tied.
BNTX and LIVN both score 70/100.
BNTX Committee View
60% agreement
5 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
LIVN Committee View
80% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- ROE of 15.4% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- Risk/reward is unfavorable: 5.6% downside vs 0.8% upside.